Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Monocentric prospective randomized controlled open phase IV study to explorate the mechanismen of the synergetic effect of the Crateagus -Extract WS 1442 in addition to endurance training related to quality of life of patients with limited physical potential caused by cardiovascular disease (Heart Failure Stade NYHA II).

Trial Profile

Monocentric prospective randomized controlled open phase IV study to explorate the mechanismen of the synergetic effect of the Crateagus -Extract WS 1442 in addition to endurance training related to quality of life of patients with limited physical potential caused by cardiovascular disease (Heart Failure Stade NYHA II).

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Feb 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Crataegus (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Dr. Willmar Schwabe Pharmaceuticals
  • Most Recent Events

    • 12 Jul 2012 Additional trial identifier 2009-111 identified as reported by German Clinical Trials Register.
    • 25 Aug 2011 New source identified and integrated (German Clinical Trials Register DRKS00000259).
    • 25 Aug 2011 Status changed from recruiting to completed as reported by German Clinical Trials Register
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top